ExLibris header image
SFX Logo
Title: Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
Source:

Science [0036-8075] Ferguson, N M yr:2016


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Constenla, D. "Assessing the economic benefits of vaccines based on the health investment life course framework: A review of a broader approach to evaluate malaria vaccination." Vaccine 33.13 (2015): 1527-1540. Link to SFX for this item
2. "Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size." Science first release 355.6331: 1302-1306. Link to SFX for this item
3. Organization, World H. "Dengue vaccine: WHO position paper, July 2016 – recommendations." Vaccine 35.9 (2017): 1200-1201. Link to SFX for this item
4. Shakhmantsir, I. "Tumors set time." Science 353.6303 (2016): 987-988. Link to SFX for this item
5. Keller, Paul A. "The Medicinal Chemistry of Dengue Fever." Journal of medicinal chemistry 52.24 (2009): 7911-7926. Link to Full Text for this item Link to SFX for this item
6. Simmons, Cameron P. "Dengue." The New England journal of medicine 366.15 (2012): 1423-1432. Link to SFX for this item
7. Galvani, Alison P. "The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes." American Naturalist, The 174.4 (2009): 565-77. Link to Full Text for this item Link to SFX for this item
8. Ozawa, S. "Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: A systematic review." Vaccine 31.1 (2012): 96-108. Link to SFX for this item
9. "Analysis of significant factors for dengue fever incidence prediction." BMC bioinformatics. 17.1: 166-166. Link to SFX for this item
10. Al-Tawfiq, Jaffar A. "Dengue Hemorrhagic Fever Virus in Saudi Arabia: A Review." Vector borne and zoonotic diseases 18.2: 75-81. Link to SFX for this item
11. Weill, F. "Genomic history of the seventh pandemic of cholera in Africa." Science 358.6364 (2017): 785-789. Link to SFX for this item
12. "Diagnosing doctors; Primary health care." The economist. 424.9055: 50-. Link to SFX for this item
13. Masri, S. "Lung Adenocarcinoma Distally Rewires Hepatic Circadian Homeostasis." Cell 165.4 (2016): 896-909. Link to SFX for this item
14. Chu, H. "CD8+ T cell Responses in Flavivirus-Naïve Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate." The Journal of infectious diseases 212.10 (2015): 1618-1628. Link to Full Text for this item Link to SFX for this item
15. Jain, V. "Discovery of fifth serotype of dengue virus (DENV-5): A new public health dilemma in dengue control." Medical journal, Armed Forces India 71.1 (2015): 67-70. Link to Full Text for this item Link to SFX for this item
16. Agresta, F. "Acute appendicitis: position paper, WSES, 2013." World Journal of Emergency Surgery 9.1 (2014): 26-26. Link to Full Text for this item Link to SFX for this item
17. Gidengil, C. "Parental and societal values for the risks and benefits of childhood combination vaccines." Vaccine 30.23 (2012): 3445-3452. Link to SFX for this item
18. Brooks, A. "Simulated Impact of RTS,S/AS01 Vaccination Programs in the Context of Changing Malaria Transmission." PLoS ONE 7.3 (2012): 1-12. Link to Full Text for this item Link to SFX for this item
19. Milani, M. "Flaviviral methyltransferase/RNA interaction: Structural basis for enzyme inhibition." Antiviral research 83.1 (2009): 28-34. Link to SFX for this item
20. Sabbatani, S. "Malaria infection and the anthropological evolution." SAUDE E SOCIEDADE 19.1 (2010): 64-83. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced